Related Experiment Videos
[A reference to know: the 2008 Chest Supplement on antithrombotic agents]
Philippe de Moerloose1, Pierre Fontana, Françoise Boehlen
1Unité d'hémostase, Département de médecine interne, Faculté de médecine de Genève HUG, 1211 Genève 14.
Abstract:
Almost every four years a Supplement of Chest about the use of antithrombotic agents is published. The recommendations come from international experts who deal among others with the use of these drugs in case of venous thromboembolic disease, atrial fibrillation, valvular and structural heart diseases, ischemic stroke, coronary diseases and peripheral artery occlusive disease. We review some recommendations about the appropriate use of anticoagulants to prevent and treat venous thromboembolic diseases as well as the use of antiplatelet agents in case of arterial diseases.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care